One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   China Patient Monitoring Market

China Patient Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Product Code : MDHC00122421
Survey : Mordor Intelligence
Publish On : 12, August, 2022
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others), Rest of World (Brazil, Rest of Latin America, Middle East & Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
 - Abbott Laboratories
- Baxter International Inc
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Draegerwerk AG
- GE Healthcare
- Johnson & Johnson
- Koninklijke Philips NV
- Medtronic PLC
- Siemens Healthcare GmbH

[Report Description]

The patient monitoring devices are the devices that are used to measure certain medical parameters by continuously measuring vital signs and repeatedly performing medical tests to ensure the well-being of the patient.

In China, chronic diseases like cardiovascular diseases are increasing at a rapid rate. Moreover, the geriatric population of China is also growing. As a result of these factors, the demand for patient monitoring devices in China has increased over the period.

The increased demand has also led to an increase in technological advancements in this field, which has eased the usage of these devices and also made them more portable. Moreover, these technologies decrease the number of unnecessary trips to the doctor’s office and reduce travel-related expenses. Hence, as a result, these devices are also being used for personal use at homes, which has also positively impacted the market growth.

Key Market Trends

Application in Cardiology is Expected to Dominate the Market

Cardiac monitoring refers to continuous or intermittent monitoring of heart activity with an assessment of the patient s condition relative to their cardiac rhythm. Additional monitoring components allow cardiovascular pressures and cardiac output to be monitored and displayed as required for patient diagnosis and treatment. Continuous cardiovascular and pulmonary monitoring allows for prompt identification and initiation of treatment.

In recent decades, the incidence of cardiovascular diseases (CVD) in China has increased. As per a 2019 report by Liu S et al., published in JAMA Cardiology 2019, CVD s prevalent cases have doubled since 1990, reaching nearly 94 million in 2016. The age-standardized prevalence rate of CVD overall has increased significantly from 1990 to 2016 by 14.7%, as did rates for ischemic heart disease (19.1%), ischemic stroke (36.6%), cardiomyopathy and myocarditis (23.1%), and endocarditis (26.7%). Therefore this has increased the prevalence and is expected to increase patient monitoring devices for cardiology applications. Hence this will help in the overall growth of the market.

Competitive Landscape

The patient monitoring market consists of several major players. China has encouraged many global companies to enter the market, and as a result, many global players in the patient monitoring market are present in the country. Moreover, some domestic players have also been competing in the Chinese market. These factors have made the region very competitive.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format

  • 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidences of Chronic Diseases due to Lifestyle Changes
4.2.2 Growth in Geriatric Population
4.2.3 Growing Preference for Home and Remote Monitoring
4.3 Market Restraints
4.3.1 High Cost of Technology
4.3.2 Stringent Regulatory Framework
4.4 Porter s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Type of Device
5.1.1 Hemodynamic Monitoring Devices
5.1.2 Neuromonitoring Devices
5.1.3 Cardiac Monitoring Devices
5.1.4 Respiratory Monitoring Devices
5.1.5 Remote Monitoring Devices
5.1.6 Other Types of Devices
5.2 By Application
5.2.1 Cardiology
5.2.2 Neurology
5.2.3 Respiratory
5.2.4 Fetal and Neonatal
5.2.5 Weight Management and Fitness Monitoring
5.2.6 Other Applications
5.3 By End User
5.3.1 Home Healthcare
5.3.2 Ambulatory Care Centers
5.3.3 Hospitals
5.3.4 Other End Users

6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Baxter International Inc
6.1.3 Becton, Dickinson and Company
6.1.4 Boston Scientific Corporation
6.1.5 Draegerwerk AG
6.1.6 GE Healthcare
6.1.7 Johnson & Johnson
6.1.8 Koninklijke Philips NV
6.1.9 Medtronic PLC
6.1.10 Siemens Healthcare GmbH


Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports